Milestone

  • Memorandum and Articles of Association Signed by the Sponsors: December 19, 1983;
  • Certificate of Incorporation as Private Ltd. Company: December 22, 1983;
  • Commercial Production Started: May 1986;
  • Converted into a Publicly Listed Company (PLC): 1989;
  • Subscription Opened on Initial Public Offerings (IPO): July 15, 1989;
  • Subscription Closed: September 14, 1989;
  • Listed in DSE: July 1990;
  • Started of Ophthalmic products: 1995;
  • Listed in CSE: December 24, 1996;
  • Company Crossed the Number of Products to 100: December 2003;
  • Natural Medicine Unit Started Production and Marketing: 2008;
  • First Dividend Declared (After IPO): March 31, 1993 in the 7th AGM;
  • First ISO-9001 Certification (ISO): August 18, 2004;
  • Started Production of Marketing of Injectable Products: December 2004;
  • Obtained Certification of Membership from BAPLC: November 30, 2005;
  • Registered as Depository Participant of CDBL: January 03, 2009;
  • Dematerialized Securities Trading Started on: January 04, 2009;
  • Commercial Production in the state-of-art Cephalosporin Plant: 2016;
  • OSD Production in Distinct Compliant Plant: 2019.